| Literature DB >> 33284579 |
Lin Li1,2, Yuting Zou3, Baoe Liu3, Runan Yang1,2, Jingjian Yang4, Minghao Sun3, Zijing Li3, Xiumei Xu1,2, Guilin Li1,2, Shuangmei Liu1,2, Wolfgang Greffrath5, Rolf-Detlef Treede5, Guodong Li1,2, Shangdong Liang1,2.
Abstract
The hippocampus is an important region for the interaction between depression and pain. Studies show that the P2X4 receptor plays key role in neuropathic pain. This work investigated the potential implication of the P2X4 receptor in the hippocampus in comorbidity of chronic pain and depression. The rat model induced by chronic constriction injury (CCI) plus unpredictable chronic mild stress (UCMS) was used in this study. Our data showed that CCI plus UCMS treatment resulted in abnormal changes in pain and depressive-like behaviors in the rat, accompanied by the upregulated expression of P2X4, NLRP3 (NOD-like receptor protein 3) inflammasome, and interleukin-1β and the activation of p38 MAPK in the hippocampus. The P2X4 antagonist 5-BDBD reversed these abnormal changes in the hippocampus, relieved hippocampal neuronal damage, and alleviated the abnormal pain and depressive-like behaviors in the CCI plus UCMS treated rats. These findings suggest that the P2X4 receptor in the hippocampus may mediate and significantly contribute to the pathological processes of comorbid pain and depression.Entities:
Keywords: P2X4 receptor; comorbidity of pain and depression; hippocampus; neuropathic pain; unpredictable chronic mild stress
Mesh:
Substances:
Year: 2020 PMID: 33284579 DOI: 10.1021/acschemneuro.0c00623
Source DB: PubMed Journal: ACS Chem Neurosci ISSN: 1948-7193 Impact factor: 5.780